1. Home
  2. Labeler Index
  3. Marnel Pharmaceuticals, Llc
  4. NDC Product Code: 0682-0475 Mar-cof Cg Expectorant

NDC 0682-0475 Mar-cof Cg Expectorant

Codeine Phosphate And Guaifenesin Syrup Oral - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 0682-0475?
  5. Mar-cof Cg Expectorant Uses
  6. Active Ingredients
  7. Active Ingredients UNII Codes
  8. Inactive Ingredients UNII Codes
  9. NDC to RxNorm Crosswalk
  10. Pharmacologic Classes
  11. Patient Education

Product Information

Get all the details for National Drug Code (NDC) 0682-0475 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
0682-0475
Proprietary Name:
Mar-cof Cg Expectorant
Non-Proprietary Name: [1]
Codeine Phosphate And Guaifenesin
Substance Name: [2]
Codeine Phosphate; Guaifenesin
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Syrup - An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler Name: [5]
Marnel Pharmaceuticals, Llc
Labeler Code:
0682
Product Label ID:
60a41229-b125-43d8-b2b4-0bf40feed764
FDA Application Number: [6]
M012
DEA Schedule: [7]
Schedule V (CV) Substances
Marketing Category: [8]
OTC MONOGRAPH DRUG -
Start Marketing Date: [9]
12-01-2008
Listing Expiration Date: [11]
12-31-2025
Exclude Flag: [12]
N
Code Navigator:

Product Characteristics

Flavor(s):
COTTON CANDY (C73382)

Code Structure Chart

Product Details

What is NDC 0682-0475?

The NDC code 0682-0475 is assigned by the FDA to the product Mar-cof Cg Expectorant which is a human over the counter drug product labeled by Marnel Pharmaceuticals, Llc. The generic name of Mar-cof Cg Expectorant is codeine phosphate and guaifenesin. The product's dosage form is syrup and is administered via oral form. The product is distributed in a single package with assigned NDC code 0682-0475-16 473 ml in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Mar-cof Cg Expectorant?

Do not exceed 6 doses in 24 hours.Adults and children 12 years of age and over1 ½ tsp (7.5 mL) every 4-6 hoursChildren 6 to under 12 years of age¾ tsp (3.75 mL) every 4-6 hoursChildren under 6 years of ageConsult a doctor

What are Mar-cof Cg Expectorant Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
  • CODEINE PHOSPHATE 7.5 mg/5mL - An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.
  • GUAIFENESIN 225 mg/5mL - An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Which are Mar-cof Cg Expectorant UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Mar-cof Cg Expectorant Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Mar-cof Cg Expectorant?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 995441 - codeine phosphate 7.5 MG / guaiFENesin 225 MG in 5 mL Oral Solution
  • RxCUI: 995441 - codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution
  • RxCUI: 995441 - codeine phosphate 7.5 MG / guaifenesin 225 MG per 5 ML Oral Solution
  • RxCUI: 995443 - MAR-COF CG 7.5 MG / 225 MG in 5 mL Oral Solution
  • RxCUI: 995443 - codeine phosphate 1.5 MG/ML / guaifenesin 45 MG/ML Oral Solution [Mar-cof CG]

Which are the Pharmacologic Classes for Mar-cof Cg Expectorant?

A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

* Please review the disclaimer below.

Patient Education

Codeine


Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. Codeine belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing. Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of codeine. If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.
[Learn More]


Guaifenesin


Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[7] What is the Drug Enforcement Administration (DEA) CV Schedule? - This is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".